Skip to main content
Log in

Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The structure of loaded solid lipid nanoparticles (SLN) has been studied to elucidate the incorporation of coenzyme Q10.

Methods. Solid-state nuclear magnetic resonance (NMR) has been applied as the principal analytical approach. In order to characterize the integration of the active ingredient coenzyme Q10 inside the solid lipid matrix, measurements of the spin-lattice relaxation time in the rotating frame have been performed.

Results. A pattern of spin diffusion between protons of the lipid and protons of the coenzyme Q10 has been observed, which indicates two different fractions of the active ingredient: whereas the majority (60%) of the coenzyme Q10 is found to be homogeneously mixed with the solid lipid, the residual amount of 40% clearly forms a separate, solid phase associated to the particles.

Conclusions. A large portion of the active ingredient has been integrated homogeneously. Another, smaller fraction forms separate domains on the nanometer scale.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. H. Müller and J. S. Lucks. Arzneistoffträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN). European Patent EP 0605497 (1996).

  2. R. H. Müller, A. Dingler, H. Weyhers, A. zur Mühlen, and W. Mehnert. Solid lipid nanoparticles (SLN) - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. III. Langzeitstabilität, Gefrier-und Sprühtrocknung. Pharm. Ind. 59:614-619 (1997).

    Google Scholar 

  3. H. Heiati, R. Tawashi, and N. C. Phillips. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencaps. 15:173-184 (1998).

    Google Scholar 

  4. C. Freitas and R. H. Müller. Spray drying of solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 46:145-151 (1998).

    Google Scholar 

  5. E. Zimmermann, R. H. Müller, and K. Mäder. Influence of different parameters on reconstitution of lyophilized SLN. Int. J. Pharm. 19:211-213 (2000).

    Google Scholar 

  6. A. Radomska, R. Dobrucki, and R. H. Müller. Chemical stability of the lipid matrices of solid lipid nanoparticles (SLN) - development of the analytical method and determination of long-term stability. Pharmazie 54:903-909 (1999).

    Google Scholar 

  7. H. Heiati, R. Tawashi, R. R. Shivers, and N. C. Phillips. Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate. Int. J. Pharm. 146:123-131 (1997).

    Google Scholar 

  8. W. Mehnert, A. zur Mählen, A. Dingler, H. Weyhers, and R. H. Müller. Solid lipid nanoparticles (SLN) - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. II. Wirkstoff-Inkorporation, Freisetzung und Sterilisierbarkeit. Pharm. Ind. 59:511-514 (1997).

    Google Scholar 

  9. S. A. Wissing and R. H. Müller. Solid lipid nanoparticles as carrier for sunscreens: in vivo release and in vivo skin penetration. J. Control. Rel. 81:225-233 (2002).

    Google Scholar 

  10. A. zur Mühlen, C. Schwarz, and W. Mehnert. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur. J. Pharm. Biopharm. 45:149-155 (1998).

    Google Scholar 

  11. V. Jenning, M. Schäfer-Korting, and S. Gohla. Vitamin A loaded solid lipid nanoparticles for topical application: drug release properties. J. Controlled Release 66:115-126 (2000).

    Google Scholar 

  12. D. B. Chen, T. Z. Yang, W. L. Lu, and Q. Zhang. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem. Pharm. Bull. 49:1444-1447 (2001).

    Google Scholar 

  13. S. A. Wissing and R. H. Müller. The influence of solid lipid nanoparticles (SLN) on skin hydration and viscoelasticity - in vivo study. Eur. J. Pharm. Biopharm. 561:67-72 (2003).

    Google Scholar 

  14. A. Fundaro, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara, and M. R. Gasco. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharm. Res. 42:337-343 (2000).

    Google Scholar 

  15. S. Yang, J. Zhu, Y. Lu, B. Liang, and C. Yang. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res. 16:751-757 (1999).

    Google Scholar 

  16. R. H. Müller, M. Radtke, and S. A. Wissing. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Del. Rev. 54:S131-S155 (2002).

    Google Scholar 

  17. S. C. Yang, L. F. Lu, Y. Cai, J. B. Zhu, B. W. Liang, and C. Z. Yang. Body distribution in vice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J. Control. Rel. 59:299-307 (1999).

    Google Scholar 

  18. R. H. Müller, W. Mehnert, J. S. Lucks, C. Schwarz, A. zur Mühlen, H. Weyhers, C. Freitas, and D. Rühl. Solid lipid nanoparticles (SLN)—Man alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41:62-69 (1995).

    Google Scholar 

  19. R. H. Müller, K. Mäder, and S. Gohla. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of thestate of the art. Eur. J. Pharm. Biopharm. 50:161-178 (2000).

    Google Scholar 

  20. W. Mehnert and K. Mäder. Solid lipid nanoparticles - production characterization and applications. Adv. Drug Del.Rev. 47:165-196 (2001).

    Google Scholar 

  21. V. Jenning and S. H. Gohla. Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int. J. Pharm. 196:219-222 (2000).

    Google Scholar 

  22. G. Lukowki, J. Kasbohm, P. Pflegel, A. Illing, and H. Wulff. Crystallographic investigation of cetyl palmitate solid lipid nanoparticles. Int. J. Pharm. 196:201-205 (2000).

    Google Scholar 

  23. V. Jenning, K. Mäder, and S. H. Gohla. Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a 1H-NMR study. Int. J. Pharm. 205:15-21 (2000).

    Google Scholar 

  24. K. Westesen and T. Wehler. Physicochemical characterization of a model intravenous oil-in-water emulsion. J. Pharm. Sci. 81:777-786 (1992).

    Google Scholar 

  25. K. Westesen and T. Wehler. Investigation of the particle size distribution of a model intravenous emulsion. J. Pharm. Sci. 82:1237-1244 (1993).

    Google Scholar 

  26. K. Westesen, A. Gerke, and M. H. J. Koch. Characterization of native and drug-loaded human low density lipoproteins. J. Pharm. Sci. 84:139-147 (1995).

    Google Scholar 

  27. K. Westesen, H. Bunjes, and M. H. J. Koch. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Rel. 48:223-226 (1997).

    Google Scholar 

  28. E. Zimmermann, S. Liedtke, R. H. Müller, and K. Mäder. 1H-NMR as a method to characterize colloidal carrier systems. Proc. Intl. Symp. Control. Rel. Bioact. Mater. 26:595-596 (1999).

    Google Scholar 

  29. S. Liedtke, E. Zimmermann, R. H. Müller, and K. Mäder. Physical characterisation of solid lipid nanoparticles (SLNTM). Proc. Intl. Symp. Control. Rel. Bioact. Mater. 26:599-600 (1999).

    Google Scholar 

  30. D. Hoffmann and C. Mayer. Cross polarization induced by temporary adsorption: NMR investigations on nanocapsule dispersions. J. Chem. Phys. 112:4242-4250 (2000).

    Google Scholar 

  31. C. Mayer. Nuclear magnetic resonance on dispersed nanoparticles. Prog. Nucl. Reson. Spectrosc. 40:307-365 (2002).

    Google Scholar 

  32. C. Mayer and G. Lukowski. Solid state NMR investigations on nanosized carrier systems. Pharm. Res. 17:486-489 (2000).

    Google Scholar 

  33. S. Guinebretiere, S. Briancon, J. Lieto, C. Mayer, and H. Fessi. Study on the emulsion-diffusion of solvent: preparation and characterization of nanocapsules. Drug Dev. Res. 57:18-33 (2002).

    Google Scholar 

  34. C. Mayer, D. Hoffmann, and M. Wohlgemuth. Structural analysis of nanocapsules by nuclear magnetic resonance. Int. J. Pharm. 242:37-46 (2002).

    Google Scholar 

  35. W. S. Veeman and W. E. J. R. Maas. Solid state NMR techniques for the study of polymer-polymer miscibility. In P. Diehl, E. Fluck, H. Günther, R. Kosfeld, and J. Seelig (eds.), NMR: Basic Principles and Progress, Springer-Verlag, Berlin, 1994, pp. 131-162.

    Google Scholar 

  36. A. Dingler. Feste Lipid-Nanopartikel als kolloidale Wirkstoffträgersysteme zur dermalen Applikation, Ph.D. Thesis, FU Berlin (1998).

  37. H. Bunjes, M. H. J. Koch, and K. Westesen. Effect of particles size on colloidal solid triglycerides. Langmuir 16:5234-5241 (2000).

    Google Scholar 

  38. K. Westesen and H. Bunjes. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int. J. Pharm. 115:129-131 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Mayer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wissing, S.A., Müller, R.H., Manthei, L. et al. Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy. Pharm Res 21, 400–405 (2004). https://doi.org/10.1023/B:PHAM.0000019291.36636.c1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000019291.36636.c1

Navigation